-
公开(公告)号:US09073918B2
公开(公告)日:2015-07-07
申请号:US13697421
申请日:2011-05-10
申请人: Lily Kwok , John David Lawson , Mark Sabat
发明人: Lily Kwok , John David Lawson , Mark Sabat
IPC分类号: C07D471/04 , A61K31/44 , C07D401/00 , C07D513/02
CPC分类号: C07D471/04
摘要: The present invention provides ALK5 inhibitors of the formula wherein the variables are as defined herein. Also provided are pharmaceutical compositions, methods of making the compounds and intermediates thereof; and methods of using the compounds.
摘要翻译: 本发明提供了下式的ALK5抑制剂,其中变量如本文所定义。 还提供了药物组合物,制备化合物及其中间体的方法; 和使用该化合物的方法。
-
公开(公告)号:US20130324528A1
公开(公告)日:2013-12-05
申请号:US13697421
申请日:2011-05-10
申请人: Lily Kwok , John David Lawson , Mark Sabat
发明人: Lily Kwok , John David Lawson , Mark Sabat
IPC分类号: C07D471/04
CPC分类号: C07D471/04
摘要: The present invention provides ALK5 inhibitors of the formula wherein the variables are as defined herein. Also provided are pharmaceutical compositions, methods of making the compounds and intermediates thereof; and methods of using the compounds.
摘要翻译: 本发明提供了下式的ALK5抑制剂,其中变量如本文所定义。 还提供了药物组合物,制备化合物及其中间体的方法; 和使用该化合物的方法。
-
公开(公告)号:US08420816B2
公开(公告)日:2013-04-16
申请号:US12796583
申请日:2010-06-08
IPC分类号: C07D471/12
CPC分类号: A61K31/541 , A61K31/4375 , A61K31/4545 , A61K31/496 , A61K31/506 , A61K31/5377 , C07D471/16
摘要: Disclosed are JAK inhibitors of formula I where G1, R1, R2, R3, R4, R5, R6, and R7 are defined in the specification. Also disclosed are pharmaceutical compositions, kits and articles of manufacture which contain the compounds, methods and materials for making the compounds, and methods of using the compounds to treat diseases, disorders, and conditions involving the immune system and inflammation, including rheumatoid arthritis, hematological malignancies, epithelial cancers (i.e., carcinomas), and other diseases, disorders or conditions associated with JAK.
摘要翻译: 公开了式I中的JAK抑制剂,其中在说明书中定义了G1,R1,R2,R3,R4,R5,R6和R7。 还公开了含有化合物的化合物,制备该化合物的方法和材料的药物组合物,试剂盒和制品,以及使用该化合物治疗涉及免疫系统和炎症的疾病,病症和病症的方法,包括类风湿性关节炎,血液学 恶性肿瘤,上皮癌(即癌)以及与JAK有关的其他疾病,病症或病症。
-
公开(公告)号:US20110053873A1
公开(公告)日:2011-03-03
申请号:US12865713
申请日:2009-01-30
申请人: Young K. Chen , Eric Wang Co , Prasuna Guntupalli , John David Lawson , Wolfgang Reinhard Ludwig Notz , Jeffrey A. Stafford , Huong-Thu Ton-Nu
发明人: Young K. Chen , Eric Wang Co , Prasuna Guntupalli , John David Lawson , Wolfgang Reinhard Ludwig Notz , Jeffrey A. Stafford , Huong-Thu Ton-Nu
IPC分类号: C07D471/04 , A61K31/497 , A61K31/4985 , A61K31/519 , A61K31/5377 , C07H17/02 , A61K31/706 , A61P35/00 , A61P25/16 , A61P25/28 , A61P29/00 , A61P19/02 , A61P9/00
CPC分类号: C07D401/10 , C07D239/84 , C07D401/14 , C07D487/04
摘要: The invention relates to HSP90 inhibiting compounds consisting of the formula: (I) wherein the variables are as defined herein. The invention also relates to pharmaceutical compositions, kits and articles of manufacture comprising such compounds; methods and intermediates useful for making the compounds; and methods of using said compounds.
摘要翻译: 本发明涉及由下式(I)组成的HSP90抑制化合物,其中变量如本文所定义。 本发明还涉及包含这些化合物的药物组合物,试剂盒和制品; 用于制备化合物的方法和中间体; 以及使用所述化合物的方法。
-
公开(公告)号:US20110136780A1
公开(公告)日:2011-06-09
申请号:US12796583
申请日:2010-06-08
IPC分类号: A61K31/4375 , C07D471/16 , A61K31/506 , A61K31/541 , A61K31/5377 , A61K31/496 , A61P37/08 , A61P17/00 , A61P11/06 , A61P19/02 , A61P25/00 , A61P17/06 , A61P11/00 , A61K31/519
CPC分类号: A61K31/541 , A61K31/4375 , A61K31/4545 , A61K31/496 , A61K31/506 , A61K31/5377 , C07D471/16
摘要: Disclosed are JAK inhibitors of formula I where G1, R1, R2, R3, R4, R5, R6, and R7 are defined in the specification. Also disclosed are pharmaceutical compositions, kits and articles of manufacture which contain the compounds, methods and materials for making the compounds, and methods of using the compounds to treat diseases, disorders, and conditions involving the immune system and inflammation, including rheumatoid arthritis, hematological malignancies, epithelial cancers (i.e., carcinomas), and other diseases, disorders or conditions associated with JAK.
摘要翻译: 公开了式I中的JAK抑制剂,其中在说明书中定义了G1,R1,R2,R3,R4,R5,R6和R7。 还公开了含有化合物的化合物,制备该化合物的方法和材料的药物组合物,试剂盒和制品,以及使用该化合物治疗涉及免疫系统和炎症的疾病,病症和病症的方法,包括类风湿性关节炎,血液学 恶性肿瘤,上皮癌(即癌)以及与JAK有关的其他疾病,病症或病症。
-
公开(公告)号:US20110136766A1
公开(公告)日:2011-06-09
申请号:US12920221
申请日:2009-03-04
申请人: Linghang Zhuang , David A. Claremon , Suresh B. Singh , Lingling Shen , Yajun Zheng , John David Lawson
发明人: Linghang Zhuang , David A. Claremon , Suresh B. Singh , Lingling Shen , Yajun Zheng , John David Lawson
IPC分类号: A61K31/675 , C07D403/12 , A61K31/517 , A61K31/496 , C07F9/06 , A61P35/02 , A61P35/00
CPC分类号: C07D403/12 , C07D413/14
摘要: Disclosed herein are Aurora kinase Inhibitors represented by Structural Formula (I): Values for the variables in Structural Formula (I) are defined herein.
摘要翻译: 本文公开了由结构式(I)表示的极光激酶抑制剂:结构式(I)中的变量的值在本文中定义。
-
-
-
-
-